An observational study to discover novel biomarkers for nivolumab in patients with advanced gastric cancer (DELIVER trial): JACCRO GC-08
Not Applicable
- Conditions
- Gastric cancer
- Registration Number
- JPRN-UMIN000030850
- Lead Sponsor
- Japan Clinical Cancer Research Organization (JACCRO)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 501
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients previously treated with nivolumab (2) HBs antigen-positive or HCV antibody-positive (3) Patients who are regarded as inadequate for study enrollment by investigators.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall Survival
- Secondary Outcome Measures
Name Time Method Response Rate, Disease Control Rate, Depth of Response, Tumor Shrinkage Rate, Tumor Progression Rate, Progression-Free Survival, Safety, Biomarker Analysis